Please try another search
AVITA Medical, Inc. reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was USD 15.2 million compared to USD 11.75 million a year ago. Revenue was USD 15.2 million compared to USD 11.75 million a year ago. Net loss was USD 15.39 million compared to USD 10.38 million a year ago. Basic loss per share from continuing operations was USD 0.6 compared to USD 0.41 a year ago. Diluted loss per share from continuing operations was USD 0.6 compared to USD 0.41 a year ago.For the six months, sales was USD 26.3 million compared to USD 22.3 million a year ago. Revenue was USD 26.3 million compared to USD 22.3 million a year ago. Net loss was USD 34.05 million compared to USD 19.6 million a year ago. Basic loss per share from continuing operations was USD 1.32 compared to USD 0.78 a year ago. Diluted loss per share from continuing operations was USD 1.32 compared to USD 0.78 a year ago.
Period Ending: | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Total Revenue | 15.2 | 11.1 | 14.2 | 13.64 |
Gross Profit | 13.08 | 9.59 | 12.4 | 11.53 |
Operating Income | -15.6 | -17.21 | -12.27 | -9.22 |
Net Income | -15.39 | -18.66 | -7.06 | -8.71 |
Period Ending: | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Total Assets | 87.83 | 97.38 | 111.64 | 81.01 |
Total Liabilities | 63.91 | 64.81 | 62.58 | 18.04 |
Total Equity | 23.92 | 32.57 | 49.06 | 62.98 |
Period Ending: | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -12.78 | -20.86 | -10.86 | -8.97 |
Cash From Investing Activities | 12.43 | 15.07 | -57.3 | 21.76 |
Cash From Financing Activities | 0.849 | 0.631 | 39.43 | 0.6 |
Net Change in Cash | 0.501 | -5.17 | -28.74 | 13.37 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review